Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Atsumasa Komori

Clin Mol Hepatol. 2024;30(4):1035-1036. Published online April 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0242

View: 1186 Download: 34

Haeryoung Kim, Sook-Hyang Jeong

Clin Mol Hepatol. 2024;30(2):291-292. Published online March 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0180

View: 2134 Download: 39 Web of Science: 1 Crossref: 1

Soomin Ahn, Sook-Hyang Jeong, Eun Ju Cho, Kyoungbun Lee, Gilhyang Kim, Haeryoung Kim

Clin Mol Hepatol. 2024;30(1):37-48. Published online November 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0325

View: 3022 Download: 198 Web of Science: 3 Crossref: 5

Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim

Clin Mol Hepatol. 2023;29(Suppl):S302-S318. Published online November 15, 2022

DOI: https://doi.org/10.3350/cmh.2022.0329

View: 6308 Download: 303 Web of Science: 14 Crossref: 17

Jeong-Ju Yoo, Sang Gyune Kim

Clin Mol Hepatol. 2023;29(2):513-515. Published online February 15, 2023

DOI: https://doi.org/10.3350/cmh.2023.0044

View: 2737 Download: 54

Shang-Chin Huang, Ja-Der Liang, Shih-Jer Hsu, Tzu-Chan Hong, Hung-Chih Yang, Jia-Horng Kao

Clin Mol Hepatol. 2021;27(2):305-312. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0301

View: 5462 Download: 167 Web of Science: 11 Crossref: 12

1 |

Viewed By 5085	MAFLD: How is it different from NAFLD?
Viewed By 5072	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 4496	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4470	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4361	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 248	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 198	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 145	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 138	MAFLD: How is it different from NAFLD?
Cited By 113	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search